KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBITDA Margin: 2009-2014

Historic EBITDA Margin for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -333.06%.

  • Biocryst Pharmaceuticals' EBITDA Margin rose 13743.00% to -132.25% in Q3 2015 from the same period last year, while for Sep 2015 it was -81.18%, marking a year-over-year increase of 12677.00%. This contributed to the annual value of -333.06% for FY2014, which is 15921.00% down from last year.
  • Biocryst Pharmaceuticals' EBITDA Margin amounted to -333.06% in FY2014, which was down 91.57% from -173.86% recorded in FY2013.
  • Biocryst Pharmaceuticals' 5-year EBITDA Margin high stood at -55.08% for FY2010, and its period low was -333.06% during FY2014.
  • Over the past 3 years, Biocryst Pharmaceuticals' median EBITDA Margin value was -173.86% (recorded in 2013), while the average stood at -218.53%.
  • In the last 5 years, Biocryst Pharmaceuticals' EBITDA Margin plummeted by 23,517bps in 2011 and then spiked by 14,156bps in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' EBITDA Margin (Yearly) stood at -55.08% in 2010, then plummeted by 23,517bps to -290.25% in 2011, then skyrocketed by 14,156bps to -148.69% in 2012, then crashed by 2,517bps to -173.86% in 2013, then plummeted by 15,921bps to -333.06% in 2014.